Goldman Sachs’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,109
| Closed | -$42K | – | 5810 |
|
|
2022
Q2 | $42K | Sell |
10,109
-26
| -0.3% | -$108 | ﹤0.01% | 5317 |
|
|
2022
Q1 | $39K | Sell |
10,135
-198
| -2% | -$762 | ﹤0.01% | 5513 |
|
|
2021
Q4 | $46K | Sell |
10,333
-800
| -7% | -$3.56K | ﹤0.01% | 5368 |
|
|
2021
Q3 | $52K | Sell |
11,133
-10,797
| -49% | -$50.4K | ﹤0.01% | 5184 |
|
|
2021
Q2 | $155K | Buy |
21,930
+4,721
| +27% | +$33.4K | ﹤0.01% | 5014 |
|
|
2021
Q1 | $102K | Sell |
17,209
-14,218
| -45% | -$84.3K | ﹤0.01% | 5035 |
|
|
2020
Q4 | $145K | Buy |
+31,427
| New | +$145K | ﹤0.01% | 4376 |
|
|
2020
Q3 | – | Sell |
-29,781
| Closed | -$857K | – | 4612 |
|
|
2020
Q2 | $857K | Buy |
+29,781
| New | +$857K | ﹤0.01% | 3318 |
|
|
2019
Q4 | – | Sell |
-27,500
| Closed | -$413K | – | 4390 |
|
|
2019
Q3 | $413K | Buy |
+27,500
| New | +$413K | ﹤0.01% | 3665 |
|